Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for CAMRF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
March 31, 2026 520.47M
December 31, 2025 515.77M
September 30, 2025 491.96M
June 30, 2025 464.21M
March 31, 2025 395.13M
December 31, 2024 340.59M
September 30, 2024 351.84M
June 30, 2024 324.08M
March 31, 2024 286.25M
December 31, 2023 189.31M
September 30, 2023 169.52M
June 30, 2023 164.20M
March 31, 2023 130.18M
December 31, 2022 125.46M
September 30, 2022 111.16M
June 30, 2022 110.54M
March 31, 2022 117.20M
December 31, 2021 119.50M
September 30, 2021 119.56M
June 30, 2021 122.28M
March 31, 2021 118.12M
December 31, 2020 128.11M
September 30, 2020 110.57M
June 30, 2020 77.64M
Date Value
March 31, 2020 73.72M
December 31, 2019 82.47M
September 30, 2019 57.51M
June 30, 2019 67.38M
March 31, 2019 75.84M
December 31, 2018 41.14M
September 30, 2018 49.64M
June 30, 2018 54.79M
March 31, 2018 52.05M
December 31, 2017 58.13M
September 30, 2017 63.76M
June 30, 2017 67.63M
March 31, 2017 66.93M
December 31, 2016 70.96M
September 30, 2016 75.75M
June 30, 2016 77.93M
March 31, 2016 83.41M
December 31, 2015 97.43M
September 30, 2015 25.06M
June 30, 2015 25.42M
March 31, 2015 24.63M
December 31, 2014 26.53M
September 30, 2014 8.906M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Orexo AB 64.08M
Swedencare AB 1.023B
Moberg Pharma AB 71.75M
Infant Bacterial Therapeutics AB 15.02M
Eli Lilly & Co. 116.58B

Total Assets (Quarterly) Related Metrics